Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
33%
Ph phase_4
1
33%
Ph phase_3
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (33.3%)
Phase 31 (33.3%)
Phase 41 (33.3%)

Trials by Status

unknown267%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
completedearly_phase_1

Effects of Sleep Deprivation and Adrenergic Inhibition on Glymphatic Flow in Humans

NCT03576664
unknownphase_4

Impact of Bariatric Surgery on Pharmacokinetic Study of Simvastatin and Carvedilol

NCT04049786
unknownphase_3

Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension

NCT01413048

Clinical Trials (3)

Showing 3 of 3 trials
NCT03576664Early Phase 1

Effects of Sleep Deprivation and Adrenergic Inhibition on Glymphatic Flow in Humans

Completed
NCT04049786Phase 4

Impact of Bariatric Surgery on Pharmacokinetic Study of Simvastatin and Carvedilol

Unknown
NCT01413048Phase 3

Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3